Global registry for benign prostatic hyperplasia treatments
A Global Registry of Treatments and Outcomes for Benign Prostatic Hyperplasia
This study is collecting information from men with benign prostatic hyperplasia to see how different treatments work and to help improve future care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7500 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Société Internationale d'Urologie Academic / other |
| Locations | 26 sites (Los Angeles, California and 25 other locations) |
| Trial ID | NCT05543200 on ClinicalTrials.gov |
What this trial studies
This ongoing international registry aims to collect demographic data and clinical outcomes for patients undergoing medical or surgical treatments for benign prostatic hyperplasia (BPH). It seeks to analyze patterns and characteristics of men receiving treatment, assess global practice patterns, and evaluate outcomes following various interventions. By standardizing outcome parameters, the registry will provide valuable real-world data that can inform future research and clinical practices in BPH management.
Who should consider this trial
Good fit: Ideal candidates for this registry are men diagnosed with symptomatic benign prostatic hyperplasia who are receiving prescribed medical treatment or surgical intervention.
Not a fit: Patients with non-symptomatic BPH or those who have not been prescribed any treatment will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of treatment outcomes and improve management strategies for patients with BPH.
How similar studies have performed: Other studies have successfully utilized registries to gather data on BPH treatments, indicating that this approach is both viable and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention Exclusion Criteria: * Non-symptomatic BPH * No treatment prescribed for BPH
Where this trial is running
Los Angeles, California and 25 other locations
- Keck Medicine of USC — Los Angeles, California, United States (Recruiting)
- Toronto Western Hospital, University Health Network — Toronto, Ontario, Canada (Recruiting)
- McGill University Health Centre — Montreal, Quebec, Canada (Recruiting)
- University of Montreal Hospital Center — Montreal, Canada (Not_yet_recruiting)
- Hospital Dr. Juan Morey La Unión — La Unión, Chile (Recruiting)
- Hospital del Trabajador — Santiago, Chile (Recruiting)
- The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, China (Recruiting)
- University of Cyprus — Nicosia, Cyprus (Not_yet_recruiting)
- The Chinese University of Hong Kong — Hong Kong, Hong Kong (Not_yet_recruiting)
- Shariati Hospital — Tehran, Iran (Recruiting)
- University of Basrah — Basra, Iraq (Recruiting)
- Azienda Ospedaliero-Universitaria Careggi — Florence, Italy (Recruiting)
- Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea — Rome, Italy (Recruiting)
- American University of Beirut — Beirut, Lebanon (Recruiting)
- Universiti Malaya — Kuala Lumpur, Malaysia (Recruiting)
- Kati University Hospital — Kati, Mali (Recruiting)
- Centro Medico Nacional Siglo XXI — Mexico City, Mexico (Recruiting)
- Benue State University Teaching Hospital, Department of Surgery — Makurdi, Nigeria (Recruiting)
- Ahmadu Bello University Teaching Hospital — Zaria, Nigeria (Recruiting)
- Institute of Kidney Diseases Peshawar — Peshawar, Pakistan (Recruiting)
- Lady Reading Hospital — Peshawar, Pakistan (Recruiting)
- Hamad Medical Corporation Qatar — Doha, Qatar (Recruiting)
- Seoul National University Bundang Hospital — Seongnam, South Korea (Not_yet_recruiting)
- Istanbul Medipol University — Istanbul, Turkey (Türkiye) (Recruiting)
- Imperial College Healthcare NHS Trust — London, United Kingdom (Not_yet_recruiting)
- Southend University Hospital — Southend-on-Sea, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Mihir Desai, MD — University of Southern California
- Study coordinator: Mihir Desai, MD
- Email: mihir.desai@med.usc.edu
- Phone: +1 (323) 865 3700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.